English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background and Aims   There is no consensus on whether iodixanol is superior to iohexol. This study aimed to compare the effects of iodixanol and iohexol on circulating endothelial microparticles (EMPs) in stable coronary artery disease (CAD) patients with diabetes mellitus (DM), and also their cytotoxic effects on human umbilical vein endothelial cells (HUVECs)  in vitro .Methods   100 CAD patients with DM were randomly assigned to receive iso-osmolar contrast medium iodixanol (group I) or low-osmolar iohexol (group II) during coronary angioplasty. An additional 49 CAD patients without DM receiving iohexol were recruited as group III. Circulating CD31 + /CD41a −  EMPs, CD62E +  EMPs, and CD31 + /CD41a +  platelet microparticles (PMPs) were determined by flow cytometry.  In vitro , the cytotoxic effects of iodixanol and iohexol on HUVECs were determined.Results   Circulating CD31 + /CD41a −  EMPs and PMPs were significantly increased after angioplasty in all 3 groups, while CD62E +  EMPs significantly decreased in group I. CD31 + /CD41a −  EMPs and PMPs were significantly higher in group II than group I or III.  In vitro , both contrast media induced EMP release and inhibited the viability and induced apoptosis of HUVECs, as well as increasing Bax and cleaved caspase-3 and decreasing Bcl-2. The above effects were less evident in iodixanol than in iohexol.Conclusions   Compared with iohexol, iodixanol induces less release of EMPs in both CAD patients with DM during angioplasty and  in vitro  HUVEC culture, which is associated with less pronounced proapoptotic effects of iodixanol on HUVECs.Clinical Study Registration Number   This study is registered with  ChiCTR-TRC-14005183 .

contrast media and molecular imaging/contrast media and molecular imaging

Iso-Osmolar Iodixanol Induces Less Increase in Circulating Endothelial Microparticles In Vivo and Less Endothelial Apoptosis In Vitro Compared with Low-Osmolar Iohexol